These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Applications of Alternative Nucleases in the Age of CRISPR/Cas9. Guha TK; Edgell DR Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020 [TBL] [Abstract][Full Text] [Related]
13. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research]. Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746 [TBL] [Abstract][Full Text] [Related]
14. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators. Chakraborty C; Teoh SL; Das S Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109 [TBL] [Abstract][Full Text] [Related]
15. Genome Editing for the Study of Cardiovascular Diseases. Chadwick AC; Musunuru K Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462 [TBL] [Abstract][Full Text] [Related]
16. [Basics and applications of genome editing technology]. Yamamoto T; Sakamoto N Rinsho Ketsueki; 2016; 57(10):1869-1873. PubMed ID: 27725582 [TBL] [Abstract][Full Text] [Related]
17. [Research progress of CRISPR-Cas9 system for gene therapy]. Zhan C; Xia X Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208 [TBL] [Abstract][Full Text] [Related]
18. Non-viral delivery of genome-editing nucleases for gene therapy. Wang M; Glass ZA; Xu Q Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355 [TBL] [Abstract][Full Text] [Related]